Brian joined us in 2000. Prior to joining us, he worked in Institutional Sales at Adams Harkness & Canaccord Genuity. Brian has been a Managing Director in Equity Capital Markets since 2008, where he has executed transactions across Growth Sectors. He started his career at The Boston Company. Brian holds a BA in English Language and Literature from The College of the Holy Cross.
Selected Transactions
-
US$35m
ASP Isotopes
Sole Bookrunner (Follow-On Offering)
-
US$125m
Galaxy Digital Holdings
Lead Underwriter (Follow-On Offering)
-
US$55m
Biodesix
Joint Bookrunner (Follow-On Offering / Priv. Placement)
-
US$100m
Regulus Therapeutics
Financial Advisor (PIPE)
-
US$100m
Harpoon Therapeutics
Placement Agent (PIPE)
-
US$659m
Klaviyo
Co-Manager (IPO)
-
US$230m
Metals Acquisition Corp
Placement Agent (PIPE)
-
US$40m
Clene
Sole Bookrunner (Follow-On)
-
US$374m
ImmunoGen
Lead Manager (Follow-On)